Legal News Articles - Drugs/Medical

Washington, DC: Bayer has announced that it is taking its female sterilization device, Essure, off the market in all countries where it is currently marketed and sold, except the US. The company said it was taking this action due to commercial reasons, and not because of allegations of side effects associated with the device.

Springfield, MA: The estate of late NFL player Aaron Hernandez on Thursday filed a federal lawsuit against the National Football League (NFL) and the New England Patriots, alleging that defendants failed to protect Hernandez from traumatic brain injury within the context of active play in football games, all the while knowing that repeated blows to the head could lead to chronic traumatic encephalopathy (CTE), an irreversible brain disease.

Madison, WI: The basket of Monsanto Roundup lawsuits has grown, with another class action launched June 20 of this year in Wisconsin (Blitz et al. v. Monsanto Company et al., Case No. 3:17-cv-00473, United States District Court, Western District of Wisconsin). In this most recent claim, plaintiffs from Wisconsin, Illinois, California, New York, New Jersey and Florida assert that the product is marketed in a false and misleading manner.

Seattle, WA A Health Benefit Trust that covers Alaskan State Employees is the lead plaintiff in a class action lawsuit against St. Jude’s Medical and Abbott Laboratories seeking compensation for costs related to defective lithium battery powered implantable cardiac defibrillators.

Washington, DC: Given the fact that Actemra is marketed without warning of heart failure, stroke, and other serious injuries like its competitors must do, one would think it is the wonder drug for rheumatoid arthritis sufferers. Until research and adverse event reports (AERS) got in the way and showed the med was just as likely to cause serious injuries as competing drugs - and given attorneys are investigating these AERS, Actemra lawsuits may be on the horizon.

Denver, CO: Law firms across the US are taking a serious interest in a recent investigative piece of journalism by STAT news published on June 5, 2017 which revealed, “The Food and Drug Administration has received reports on 1,128 people who died after taking Actemra, and has reviewed its safety several times since it was approved. But the agency doesn’t have sophisticated tools to determine whether the drug was a culprit or a bystander in those deaths.”

Los Angeles, CA: Despite lack of consensus in the scientific community directly associating talcum powder with the risk of ovarian cancer, jurors have sided with plaintiffs rather than Johnson & Johnson in four out of six talcum powder lawsuits that have gone to trial.

Seattle, WA: One of the world’s leading manufacturers of endoscopes, and a target of a wrongful death trial in an endoscope lawsuit, escaped liability for a patient’s fatal infection but was nonetheless compelled to pay almost $6.6 million to the hospital involved for failing to adequately instruct hospital staff.

Washington, DC: The honeymoon the then-fresh Obama Administration was still largely enjoying in 2010 was nonetheless tainted two years into Barack Obama’s Presidency with revelations that hundreds of Americans supposedly had died due to malfunctioning infusion pumps. The Medtronic SynchroMed insulin pump was among the plethora of infusion pumps that were coming under increased scrutiny by the US Food and Drug Administration (FDA) at the time.